Kamil Ali-Jackson, Chief Legal Officer at Aclaris Therapeutics, Inc. (ACRS), sold 18,984 shares at $21.96 ($417K) on 2021-06-03, disclosed to the SEC on 2021-06-04.
Open-market sale of $417k ACRS by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.96 | 9,492 | $208K | 50.0% |
| 2 | $21.96 | 9,492 | $208K | 50.0% |
| Total | $21.96 avg | 18,984 | $417K | 100% |
| Filing → |
| PDSB | BUY | 2021-06-17 | $100K | — | Filing → |
| ACRS | SELL | 2021-06-02 | $2.0M | — | Filing → |
| ACRS | SELL | 2021-05-07 | $907K | — | Filing → |